Skip to main content
. 2020 May 10;11(3):453–464. doi: 10.4103/idoj.IDOJ_280_20

Table 3.

Approved and unapproved uses of HCQ[9]

FDA approved Lupus erythematosus Rheumatoid arthritis Malaria

Off label
Photosensitivity disorders PCT, PMLE, solar urticaria, chronic actinic dermatitis, and hydroa vacciniforme
Granulomatous disorders Sarcoidosis, granuloma annulare, LMDF, and granulomatous cheilitis
CT disorders Dermatomyositis, scleredema, and LE
Disorders with Lymphocytic Infiltrate Jessner’s infiltrate and lymphocytoma cutis
Panniculitis Lupus panniculitis and erythema nodosum
Miscellaneous Alopecia areata
Atopic dermatitis
Eosinophilic fasciitis
Follicular mucinosis
Lichen nitidus
Lichen planus
Morphea
Psoriatic arthritis
Ulcerative stomatitis
Urticarial vasculitis
Infections HIV, influenza, SARS-CoV, and SARS-CoV2 (COVID-19)